翰思艾泰生物医药科技（武汉）股份有限公司（股票代码：03378，以下简称“翰思艾泰-B”）于2026年4月14日发布公告，披露公司于2026年4月13日在香港联交所场内回购46,000股H股，占已发行股本约0.034%。本次回购每股价格介乎港币28.68港元至30.70港元，涉资总额约1,374,486港元。公告显示，本次变动后公司已发行股本（不包括库藏股）为136,063,030股，库藏股数量为155,800股，合计136,218,830股。
公告提及，本次回购依据2026年2月12日获股东大会通过的购回授权，授权总数为13,621,883股。截至目前，公司已累计回购155,800股。公司确认已遵守相关上市规则及法律规定。本公告由董事长兼执行董事张发明签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.